Robert Hulick, MD
Orthopaedic Surgery · Mobile, ALNPI 1427469592
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $15,941 with a category attached, or 62.7%. Arthrex accounts for 62.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $11,318 and has fallen 98.1% since, to $214 in 2025.
Across 54 payments — averaging $295.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Zimmer Biomet$2K
- Elite Orthopedics, LLC$1K
- Medical Device Business Services, Inc.$1K
- Stryker$972
- Johnson & Johnson$516
- plus $642 from 16 others
What the payments were for
- Consulting fees$1,0056%
- Grants$10,00063%
- Travel & lodging$2,29914%
- Food & beverage$1,4379%
- Education$1,2008%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $10,000 |
| Zimmer Biomet | 12 | $1,603 |
| Elite Orthopedics, LLC | 2 | $1,203 |
| Medical Device Business Services, Inc. | 1 | $1,005 |
| Stryker | 6 | $972 |
| Johnson & Johnson | 5 | $516 |
| DJO, LLC | 4 | $143 |
| Heraeus Medical, LLC. | 3 | $62 |
| Radius Health, Inc. | 3 | $58 |
| Biocomposites Inc | 1 | $54 |
| Organogenesis Inc. | 3 | $54 |
| BD | 1 | $51 |
| Si-bone, Inc. | 1 | $34 |
| Orthofix Medical, Inc. | 2 | $33 |
| Smith+Nephew | 2 | $32 |
| Kerecis Limited | 1 | $23 |
| Vertex | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Innovation Technologies Inc | 1 | $15 |
| Linvatec Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,941 in reported general payments places this provider in the 80th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 426 | $1,409 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 75 | $663 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $646 |
| Tramadol Hcl | 202 | $631 |
| Ibuprofen | 81 | $616 |
| Methocarbamol | 31 | $412 |
| Tizanidine Hcl | 55 | $314 |
| Gabapentin | 48 | $265 |
| Cyclobenzaprine Hcl | 56 | $243 |
| Celecoxib | 16 | $220 |
| Ondansetron Hcl | 30 | $187 |
| Pregabalin | 16 | $175 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mobile
- Matthew BarberMobile$158K
- Joseph ZarzourMobile$68K
- Russell GoodeMobile$43K
- Jess MullensMobile$33K
- Clinton HowardMobile$24K
- Blake BowdenMobile$22K
- David DonahoeMobile$21K
- Albert HaasMobile$19K
- Jeffrey BrewerMobile$18K
- Jeffrey DugasBirmingham$11.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.